As of 2024-12-12, the Intrinsic Value of Santhera Pharmaceuticals Holding AG (SANN.SW) is 161.99 CHF. This SANN.SW valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 9.89 CHF, the upside of Santhera Pharmaceuticals Holding AG is 1,537.90%.

The range of the Intrinsic Value is 116.61 - 267.73 CHF

	Range	Selected	Upside
a
DCF (Growth 5y)	116.61 - 267.73	161.99	1537.9%
DCF (Growth 10y)	122.46 - 270.79	167.27	1591.3%
DCF (EBITDA 5y)	94.94 - 115.92	104.20	953.6%
DCF (EBITDA 10y)	110.25 - 146.16	126.02	1174.2%
Fair Value	35.13 - 35.13	35.13	255.24%
P/E	65.63 - 196.39	80.29	711.9%
EV/EBITDA	56.94 - 105.22	74.80	656.3%
EPV	8.18 - 15.53	11.86	19.9%
DDM - Stable	55.69 - 176.41	116.05	1073.4%
DDM - Multi	58.44 - 154.43	86.02	769.7%